Jordi Monés, MD, PhD, explains why RP and Stargardt data support testing son-vec to restore vision in advanced GA.
Jordi Mones, MD, PhD
Advertisement
Jordi Monés, MD, PhD, is director of Institut de la Màcula in Barcelona, Spain, and adjunct professor at the John A. Moran Eye Center, University of Utah in Salt Lake City.
Articles by Jordi Mones, MD, PhD
At EURETINA 2026, Jordi Monés, MD, PhD, outlined the rationale for gene-agnostic optogenetic therapy MCO-010 to restore vision in Stargardt disease and geographic atrophy.
Jordi Mones, MD, PhD, discusses what is believed to be the first direct-to-phase 2 trial testing an optogenetic gene therapy to restore vision lost to GA.
Advertisement
Latest Updated Articles
An optogenetic approach to treating geographic atrophySeptember 2nd 2026
Advertisement
Advertisement
Trending on Eye Care Network - Ophthalmology Times
1
Practical ways to extend anti-VEGF control in RVO, AMD, and DME
2
Comments from the FDA Advisory Committee meeting on SYD-101
3
Mediterranean diet linked to slower AMD progression across stages
4
Lambert-Eaton Myasthenic Syndrome: how eye care professionals differentiate it from myasthenia gravis
5